No products in the cart.
Lemborexant Tablets 10?mg – Dayvigo Low price wholesale
$1.00
Lemborexant Tablets (brand name: Dayvigo ) contain 10?mg per tablet, with 28 tablets per box. Manufactured by Eisai Manufacturing Ltd. (UK), and approved in China under NMPA HJ20250057. This compound is an orexin receptor antagonist used in sleep, CNS, and circadian rhythm disorder research models.?? For research use only.?Please consult staff for other specifications and uses?
Description
Lemborexant Tablets (brand name: Dayvigo ) contain 10?mg per tablet, with 28 tablets per box. Manufactured by Eisai Manufacturing Ltd. (UK), and approved in China under NMPA HJ20250057. This compound is an orexin receptor antagonist used in sleep, CNS, and circadian rhythm disorder research models.
?? For research use only. Not for human or veterinary consumption.
Lemborexant (Dayvigo) is a dual orexin receptor antagonist (DORA) that selectively binds to OX1R and OX2R receptors, blocking wake-promoting neuropeptides. This action helps induce sleep and maintain sleep duration. In research, it is used to investigate:
Insomnia mechanisms
Circadian rhythm dysregulation
Neurotransmitter signaling in sleep-wake cycles
Hypothalamic neural circuitry
Lemborexant Tablets Product Specifications
| Parameter | Details |
|---|---|
| Product Name | Lemborexant Tablets (Dayvigo / ???) |
| Generic Name | Lemborexant |
| CAS Number | 1369764-02-2 |
| Molecular Formula | C22H20F1N5O2 |
| Molecular Weight | 405.43?g/mol |
| Formulation | Oral tablet |
| Strength | 10?mg per tablet |
| Pack Size | 28 tablets (2 blisters × 14 tablets) |
| Dosage Form | Tablet |
| Approval Number | HJ20250057 (China NMPA) |
| Pharmaceutical Code | 86979086000771 |
| Manufacturer | Eisai Manufacturing Ltd., UK |
| Storage | Store in a cool, dry place (15–25?°C), avoid light and heat |
| Intended Use | Laboratory research only |
Lemborexant Tablets Mechanism of Action
Lemborexant is a dual orexin receptor antagonist (DORA), inhibiting both OX1R and OX2R receptors. These receptors regulate wakefulness, and their inhibition decreases neuronal activity in the arousal centers of the brain, enabling sleep induction and maintenance.
Its selective, non-sedative profile makes it ideal for sleep architecture studies, REM/non-REM analysis, and drug interaction models.
Research Applications
Sleep-onset and sleep-maintenance insomnia
Orexin pathway studies
Circadian rhythm dysfunction
Jet lag and shift work disorder
Comparative hypnotic pharmacology
Neuropsychiatric disorder research (depression, anxiety)
Safety & Handling
Lab use only; not for ingestion
Use personal protective equipment (PPE)
Avoid exposure to eyes, skin, or mucosa
COA and SDS available on request
Research Use Disclaimer
This product is intended exclusively for research use. It is not approved for clinical, therapeutic, or veterinary use. Misuse may lead to health risks. Follow all safety guidelines and local regulations.
Additional information
| Weight | 1 kg |
|---|---|
| Dimensions | 28 × 26 × 28 cm |
Q1: What is the function of Lemborexant in research?
A1: It’s used to study sleep-wake cycles by blocking orexin receptors that regulate arousal and alertness.
Q2: Is this product suitable for insomnia models?
A2: Yes, it is widely used in rodent and non-human primate insomnia and sleep-onset latency models.
Q3: What distinguishes Lemborexant from other sleep agents?
A3: It acts via orexin inhibition, not GABA modulation, reducing the risk of dependency or residual sedation in preclinical models.
Q4: Can I buy in bulk?
A4: Yes, both wholesale and small-quantity orders are supported.
Q5: Is Dayvigo approved for human use?
A5: Yes, globally. But this product is strictly for laboratory research and not intended for therapeutic use.
Q6: Is documentation provided?
A6: COA (Certificate of Analysis), SDS (Safety Data Sheet), and import/export support available upon request.
Related products
Pramipexole Dihydrochloride ER Tablets 0.375mg Low price wholesale
Pramipexole Dihydrochloride Extended-Release Tablets (Lisuo) deliver 0.375?mg per tablet in a sustained-release formulation. Manufactured by LIPIN Pharmaceuticals (Xiamen) Co., Ltd., this product is approved under NMPA H20213113. It is ideal for scientific research into dopaminergic modulation, Parkinson's disease (PD), and restless legs syndrome (RLS).?? Strictly for laboratory research use only.?Please consult staff for other specifications and uses?
$1.00Sertraline Hydrochloride Capsules 50?mg Low price wholesale
Sertraline Hydrochloride Capsules contain 50?mg of active SSRI compound per capsule. Each box includes 14 capsules × 3 blisters (42 capsules total). Manufactured by Sichuan Baicao Pharmaceutical Co., Ltd. and approved under NMPA H20070179, this product is suitable for laboratory research on depression, anxiety, and PTSD-related behavior models.?? Intended for laboratory research use only.?Please consult staff for other specifications and uses?
$5.00Pregabalin Capsules 150?mg Factory low price wholesale
Pregabalin is a GABA analogue and calcium channel modulator used extensively in preclinical and academic research on neuropathic pain, epilepsy, fibromyalgia, and anxiety. Supplied as 150?mg capsules in a 32-count box (8 capsules × 4 blisters), this product is manufactured by Shijiazhuang Longze Pharmaceutical Co., Ltd., and is approved in China under NMPA H20213706.?? Strictly for laboratory research use.?Please consult staff for other specifications and uses? $2.00Rasagiline Mesylate Tablets 1?mg Low price wholesale
Rasagiline Mesylate is a selective and irreversible monoamine oxidase-B (MAO-B) inhibitor supplied as 1mg film-coated tablets. Manufactured by Zhejiang Huahai Pharmaceutical Co., Ltd., this product is approved in China under H20243784 and is intended strictly for laboratory research use only.?? Not for human or veterinary use.?Please consult staff for other specifications and uses? $3.00
Reviews
There are no reviews yet.